Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
0.799
-0.041 (-4.84%)
At close: Oct 29, 2024, 4:00 PM
0.798
-0.001 (-0.18%)
After-hours: Oct 29, 2024, 4:45 PM EDT
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $117.02 million as of October 29, 2024. Its market cap has increased by 52.57% in one year.
Market Cap
117.02M
Enterprise Value
101.55M
1-Year Change
52.57%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since February 11, 1999, Veru Inc.'s market cap has increased from $17.00M to $117.02M, an increase of 588.35%. That is a compound annual growth rate of 7.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 28, 2024 | 123.00M | 82.49% |
Dec 29, 2023 | 67.40M | -84.17% |
Dec 30, 2022 | 425.70M | -9.69% |
Dec 31, 2021 | 471.40M | -22.24% |
Dec 31, 2020 | 606.20M | 178.20% |
Dec 31, 2019 | 217.90M | 148.46% |
Dec 31, 2018 | 87.70M | 44.48% |
Dec 29, 2017 | 60.70M | 112.98% |
Dec 30, 2016 | 28.50M | -32.30% |
Dec 31, 2015 | 42.10M | -62.74% |
Dec 31, 2014 | 113.00M | -53.73% |
Dec 31, 2013 | 244.20M | 18.60% |
Dec 31, 2012 | 205.90M | 63.80% |
Dec 30, 2011 | 125.70M | -19.63% |
Dec 31, 2010 | 156.40M | 24.42% |
Dec 31, 2009 | 125.70M | 30.39% |
Dec 31, 2008 | 96.40M | 38.31% |
Dec 31, 2007 | 69.70M | 85.87% |
Dec 29, 2006 | 37.50M | -7.64% |
Dec 30, 2005 | 40.60M | -11.74% |
Dec 31, 2004 | 46.00M | -14.34% |
Dec 31, 2003 | 53.70M | 88.42% |
Dec 31, 2002 | 28.50M | 139.50% |
Dec 31, 2001 | 11.90M | 80.30% |
Dec 29, 2000 | 6.60M | -54.79% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Annovis Bio | 128.84M |
Outlook Therapeutics | 128.69M |
Verastem | 127.98M |
Immunic | 125.21M |
Nutex Health | 123.05M |
23andMe Holding Co. | 120.66M |
Aclaris Therapeutics | 120.57M |
Seres Therapeutics | 119.97M |